Advertisement
Screener

BIOMERICA INC (BMRA) Cost of Revenue

2.4 / 5 stars · 56/119 Roast Me

BIOMERICA INC Cost of Revenue

BIOMERICA INC (BMRA) reported Cost of Revenue of $4.09 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.

Financial Statements › Expense Statement

us-gaap:CostOfRevenue · last filed 2026-08-31

  • BIOMERICA INC cost of revenue for the quarter ending 2026-05-31 was $946.00K, a 4.73% decline year-over-year.
  • BIOMERICA INC cost of revenue for the quarter ending 2026-02-28 was $1.03M, a 6.27% decline year-over-year.
  • BIOMERICA INC cost of revenue for the quarter ending 2025-11-30 was $1.16M, a 3.34% decline year-over-year.
  • BIOMERICA INC cost of revenue for the quarter ending 2025-08-31 was $956.00K, a 37.02% decline year-over-year.
  • BIOMERICA INC cost of revenue for fiscal 2026 was $4.09M, a 15.00% decline from fiscal 2025.
  • BIOMERICA INC cost of revenue for fiscal 2025 was $4.81M, a 0.19% increase from fiscal 2024.
  • BIOMERICA INC cost of revenue for fiscal 2024 was $4.80M, a 1.82% decline from fiscal 2023.
  • BIOMERICA INC cost of revenue for fiscal 2023 was $4.89M, a 69.21% decline from fiscal 2022.
Period endCost of Revenue 3 monthCost of Revenue 3 month as first filedCost of Revenue 6 monthCost of Revenue 6 month as first filedCost of Revenue 9 monthCost of Revenue 9 month as first filedCost of Revenue 12 monthCost of Revenue 12 month as first filed
2026-05-31$946.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31
$1.98M
derived: sum of 2 quarters · filed 2026-08-31
$3.14M
derived: sum of 3 quarters · filed 2026-08-31
$4.09M
10-K · filed 2026-08-31
2026-02-28$1.03M
10-Q · filed 2026-04-13
$2.19M
derived: sum of 2 quarters · filed 2026-04-13
$3.15M
10-Q · filed 2026-04-13
$4.14M
derived: sum of 4 quarters · filed 2026-08-31
2025-11-30$1.16M
10-Q · filed 2026-01-14
$2.11M
10-Q · filed 2026-01-14
$3.11M
derived: sum of 3 quarters · filed 2026-08-31
$4.21M
derived: sum of 4 quarters · filed 2026-08-31
2025-08-31$956.00K
10-Q · filed 2025-10-14
$1.95M
derived: sum of 2 quarters · filed 2026-08-31
$3.05M
derived: sum of 3 quarters · filed 2026-08-31
$4.25M
derived: sum of 4 quarters · filed 2026-08-31
2025-05-31$993.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31
$2.09M
derived: sum of 2 quarters · filed 2026-08-31
$3.29M
derived: sum of 3 quarters · filed 2026-08-31
$4.81M
10-K · filed 2026-08-31
2025-02-28$1.10M
10-Q · filed 2026-04-13
$2.30M
derived: sum of 2 quarters · filed 2026-04-13
$3.82M
10-Q · filed 2026-04-13
$4.91M
derived: sum of 4 quarters · filed 2026-04-13
2024-11-30$1.20M
10-Q · filed 2026-01-14
$2.72M
10-Q · filed 2026-01-14
$3.81M
derived: sum of 3 quarters · filed 2026-01-14
$4.98M
derived: sum of 4 quarters · filed 2026-01-14
2024-08-31$1.52M
10-Q · filed 2025-10-14
$2.61M
derived: sum of 2 quarters · filed 2025-10-14
$3.78M
derived: sum of 3 quarters · filed 2025-10-14
$5.02M
derived: sum of 4 quarters · filed 2025-10-14
2024-05-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29
$2.26M
derived: sum of 2 quarters · filed 2025-08-29
$3.50M
derived: sum of 3 quarters · filed 2025-08-29
$4.80M
10-K · filed 2025-08-29
2024-02-29$1.17M
10-Q · filed 2025-04-14
$2.41M
derived: sum of 2 quarters · filed 2025-04-14
$3.71M
10-Q · filed 2025-04-14
$4.79M
derived: sum of 4 quarters · filed 2025-04-14
2023-11-30$1.24M
10-Q · filed 2025-01-14
$2.54M
10-Q · filed 2025-01-14
$3.62M
derived: sum of 3 quarters · filed 2025-01-14
$4.61M
derived: sum of 4 quarters · filed 2025-01-14
2023-08-31$1.30M
10-Q · filed 2024-10-15
$2.38M
derived: sum of 2 quarters · filed 2024-10-15
$3.37M
derived: sum of 3 quarters · filed 2024-10-15
$4.50M
derived: sum of 4 quarters · filed 2024-10-15
2023-05-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28
$2.07M
derived: sum of 2 quarters · filed 2024-08-28
$3.20M
derived: sum of 3 quarters · filed 2024-08-28
$4.89M
10-K · filed 2024-08-28
2023-02-28$991.00K
10-Q · filed 2024-04-12
$991.17K
10-Q · filed 2023-04-14
$2.12M
derived: sum of 2 quarters · filed 2024-04-12
$3.81M
10-Q · filed 2024-04-12
$3.81M
10-Q · filed 2023-04-14
$8.49M
derived: sum of 4 quarters · filed 2024-04-12
2022-11-30$1.13M
10-Q · filed 2024-01-16
$1.13M
10-Q · filed 2023-01-13
$2.82M
10-Q · filed 2024-01-16
$2.82M
10-Q · filed 2023-01-13
$7.50M
derived: sum of 3 quarters · filed 2024-01-16
$13.49M
derived: sum of 4 quarters · filed 2024-01-16
2022-08-31$1.69M
10-Q · filed 2023-10-12
$1.69M
10-Q · filed 2022-10-13
$6.37M
derived: sum of 2 quarters · filed 2023-10-12
$12.36M
derived: sum of 3 quarters · filed 2023-10-12
$16.24M
derived: sum of 4 quarters · filed 2023-10-12
2022-05-31$4.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25
$10.67M
derived: sum of 2 quarters · filed 2023-08-25
$14.54M
derived: sum of 3 quarters · filed 2023-08-25
$15.89M
10-K · filed 2023-08-25
$15.89M
10-K · filed 2022-08-29
2022-02-28$5.99M
10-Q · filed 2023-04-14
$9.86M
derived: sum of 2 quarters · filed 2023-04-14
$11.21M
10-Q · filed 2023-04-14
$12.25M
derived: sum of 4 quarters · filed 2023-04-14
2021-11-30$3.88M
10-Q · filed 2023-01-13
$5.23M
10-Q · filed 2023-01-13
$6.27M
derived: sum of 3 quarters · filed 2023-01-13
$9.97M
derived: sum of 4 quarters · filed 2023-01-13
2021-08-31$1.35M
10-Q · filed 2022-10-13
$2.39M
derived: sum of 2 quarters · filed 2022-10-13
$6.09M
derived: sum of 3 quarters · filed 2022-10-13
$7.16M
derived: sum of 4 quarters · filed 2022-10-13
2021-05-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29
$4.74M
derived: sum of 2 quarters · filed 2022-08-29
$5.81M
derived: sum of 3 quarters · filed 2022-08-29
$6.83M
10-K · filed 2022-08-29
$6.70M
10-K · filed 2021-08-27
2021-02-28$3.70M
10-Q · filed 2022-04-14
$3.67M
10-Q · filed 2021-04-14
$4.77M
derived: sum of 2 quarters · filed 2022-04-14
$5.79M
10-Q · filed 2022-04-14
$5.64M
10-Q · filed 2021-04-14
$7.83M
derived: sum of 4 quarters · filed 2022-04-14
2020-11-30$1.06M
10-Q · filed 2022-01-12
$1.01M
10-Q · filed 2021-01-14
$2.09M
10-Q · filed 2022-01-12
$1.97M
10-Q · filed 2021-01-14
$4.12M
derived: sum of 3 quarters · filed 2022-01-12
$5.09M
derived: sum of 4 quarters · filed 2022-01-12
2020-08-31$1.03M
10-Q · filed 2021-10-14
$960.93K
10-Q · filed 2020-10-15
$3.06M
derived: sum of 2 quarters · filed 2021-10-14
$4.03M
derived: sum of 3 quarters · filed 2021-10-14
$5.15M
derived: sum of 4 quarters · filed 2021-10-14
2020-05-31$2.03M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14
$3.00M
derived: sum of 2 quarters · filed 2021-10-14
$4.13M
derived: sum of 3 quarters · filed 2021-10-14
$4.95M
10-K/A · filed 2021-10-14
$4.91M
10-K · filed 2020-08-31
2020-02-29$964.91K
10-Q · filed 2021-04-14
$2.09M
derived: sum of 2 quarters · filed 2021-04-14
$2.92M
10-Q · filed 2021-04-14
$3.90M
derived: sum of 4 quarters · filed 2021-04-14
2019-11-30$1.13M
10-Q · filed 2021-01-14
$1.95M
10-Q · filed 2021-01-14
$2.94M
derived: sum of 3 quarters · filed 2021-01-14
$3.83M
derived: sum of 4 quarters · filed 2021-01-14
2019-08-31$827.11K
10-Q · filed 2020-10-15
$1.81M
derived: sum of 2 quarters · filed 2020-10-15
$2.71M
derived: sum of 3 quarters · filed 2020-10-15
$3.80M
derived: sum of 4 quarters · filed 2020-10-15
2019-05-31$985.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31
$1.88M
derived: sum of 2 quarters · filed 2020-08-31
$2.97M
derived: sum of 3 quarters · filed 2020-08-31
$3.91M
10-K · filed 2020-08-31
2019-02-28$895.24K
10-Q · filed 2020-04-14
$1.99M
derived: sum of 2 quarters · filed 2020-04-14
$2.92M
10-Q · filed 2020-04-14
$3.79M
derived: sum of 4 quarters · filed 2020-04-14
2018-11-30$1.09M
10-Q · filed 2020-01-14
$2.03M
10-Q · filed 2020-01-14
$2.89M
derived: sum of 3 quarters · filed 2020-01-14
$3.80M
derived: sum of 4 quarters · filed 2020-01-14
2018-08-31$935.65K
10-Q · filed 2019-10-15
$1.80M
derived: sum of 2 quarters · filed 2019-10-15
$2.71M
derived: sum of 3 quarters · filed 2019-10-15
$3.82M
derived: sum of 4 quarters · filed 2019-10-15
2018-05-31$862.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29
$1.77M
derived: sum of 2 quarters · filed 2019-08-29
$2.88M
derived: sum of 3 quarters · filed 2019-08-29
$3.81M
10-K · filed 2019-08-29
2018-02-28$910.29K
10-Q · filed 2019-04-15
$2.02M
derived: sum of 2 quarters · filed 2019-04-15
$2.95M
10-Q · filed 2019-04-15
$3.96M
derived: sum of 4 quarters · filed 2019-04-15
2017-11-30$1.11M
10-Q · filed 2019-01-14
$2.04M
10-Q · filed 2019-01-14
$3.05M
derived: sum of 3 quarters · filed 2019-01-14
$4.10M
derived: sum of 4 quarters · filed 2019-01-14
2017-08-31$929.91K
10-Q · filed 2018-10-15
$1.94M
derived: sum of 2 quarters · filed 2018-10-15
$2.99M
derived: sum of 3 quarters · filed 2018-10-15
$3.87M
derived: sum of 4 quarters · filed 2018-10-15
2017-05-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29
$2.06M
derived: sum of 2 quarters · filed 2018-08-29
$2.94M
derived: sum of 3 quarters · filed 2018-08-29
$3.77M
10-K · filed 2018-08-29
2017-02-28$1.05M
10-Q · filed 2018-04-16
$1.93M
derived: sum of 2 quarters · filed 2018-04-16
$2.76M
10-Q · filed 2018-04-16
$3.74M
derived: sum of 4 quarters · filed 2018-04-16
2016-11-30$875.52K
10-Q · filed 2018-01-17
$1.71M
10-Q · filed 2018-01-17
$2.69M
derived: sum of 3 quarters · filed 2018-01-17
$3.71M
derived: sum of 4 quarters · filed 2018-01-17
2016-08-31$833.15K
10-Q · filed 2017-10-16
$1.81M
derived: sum of 2 quarters · filed 2017-10-16
$2.83M
derived: sum of 3 quarters · filed 2017-10-16
$3.58M
derived: sum of 4 quarters · filed 2017-10-16
2016-05-31$980.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29
$2.00M
derived: sum of 2 quarters · filed 2017-08-29
$2.75M
derived: sum of 3 quarters · filed 2017-08-29
$3.62M
10-K · filed 2017-08-29
2016-02-29$1.02M
10-Q · filed 2017-04-14
$1.77M
derived: sum of 2 quarters · filed 2017-04-14
$2.64M
10-Q · filed 2017-04-14
$3.66M
derived: sum of 4 quarters · filed 2017-04-14
2015-11-30$753.04K
10-Q · filed 2017-01-17
$1.62M
10-Q · filed 2017-01-17
$2.65M
derived: sum of 3 quarters · filed 2017-01-17
$3.49M
derived: sum of 4 quarters · filed 2017-01-17
2015-08-31$865.57K
10-Q · filed 2016-10-17
$1.89M
derived: sum of 2 quarters · filed 2016-10-17
$2.74M
derived: sum of 3 quarters · filed 2016-10-17
$3.56M
derived: sum of 4 quarters · filed 2016-10-17
2015-05-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29
$1.87M
derived: sum of 2 quarters · filed 2016-08-29
$2.70M
derived: sum of 3 quarters · filed 2016-08-29
$3.42M
10-K · filed 2016-08-29
2015-02-28$840.57K
10-Q · filed 2016-04-14
$1.67M
derived: sum of 2 quarters · filed 2016-04-14
$2.39M
10-Q · filed 2016-04-14
$3.50M
derived: sum of 4 quarters · filed 2016-04-14
2014-11-30$826.36K
10-Q · filed 2016-01-14
$1.55M
10-Q · filed 2016-01-14
$2.66M
derived: sum of 3 quarters · filed 2016-01-14
$3.57M
derived: sum of 4 quarters · filed 2016-01-14
2014-08-31$724.54K
10-Q · filed 2015-10-15
$1.83M
derived: sum of 2 quarters · filed 2015-10-15
$2.74M
derived: sum of 3 quarters · filed 2015-10-15
$3.42M
derived: sum of 4 quarters · filed 2015-10-15
2014-05-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31
$2.02M
derived: sum of 2 quarters · filed 2015-08-31
$2.70M
derived: sum of 3 quarters · filed 2015-08-31
$3.45M
10-K · filed 2015-08-31
2014-02-28$914.16K
10-Q · filed 2015-04-14
$1.59M
derived: sum of 2 quarters · filed 2015-04-14
$2.35M
10-Q · filed 2015-04-14
$3.34M
derived: sum of 4 quarters · filed 2015-04-14
2013-11-30$679.20K
10-Q · filed 2015-01-14
$1.43M
10-Q · filed 2015-01-14
$2.42M
derived: sum of 3 quarters · filed 2015-01-14
$3.39M
derived: sum of 4 quarters · filed 2015-01-14
2013-08-31$753.45K
10-Q · filed 2014-10-15
$1.74M
derived: sum of 2 quarters · filed 2014-10-15
$2.71M
derived: sum of 3 quarters · filed 2014-10-15
$3.83M
derived: sum of 4 quarters · filed 2014-10-15
2013-05-31$989.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29
$1.96M
derived: sum of 2 quarters · filed 2014-08-29
$3.08M
derived: sum of 3 quarters · filed 2014-08-29
$4.05M
10-K · filed 2014-08-29
2013-02-28$971.32K
10-Q · filed 2014-04-14
$2.09M
derived: sum of 2 quarters · filed 2014-04-14
$3.06M
10-Q · filed 2014-04-14
$4.05M
derived: sum of 4 quarters · filed 2014-04-14
2012-11-30$1.11M
10-Q · filed 2014-01-14
$2.08M
10-Q · filed 2014-01-14
$3.08M
derived: sum of 3 quarters · filed 2014-01-14
$4.03M
derived: sum of 4 quarters · filed 2014-01-14
2012-08-31$969.69K
10-Q · filed 2013-10-15
$1.97M
derived: sum of 2 quarters · filed 2013-10-15
$2.91M
derived: sum of 3 quarters · filed 2013-10-15
$3.86M
derived: sum of 4 quarters · filed 2013-10-15
2012-05-31$995.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29
$1.94M
derived: sum of 2 quarters · filed 2013-08-29
$2.89M
derived: sum of 3 quarters · filed 2013-08-29
$3.78M
10-K · filed 2013-08-29
2012-02-29$947.83K
10-Q · filed 2013-04-15
$1.90M
derived: sum of 2 quarters · filed 2013-04-15
$2.79M
10-Q · filed 2013-04-15
$3.67M
derived: sum of 4 quarters · filed 2013-04-15
2011-11-30$949.20K
10-Q · filed 2013-01-14
$1.84M
10-Q · filed 2013-01-14
$2.72M
derived: sum of 3 quarters · filed 2013-01-14
$3.57M
derived: sum of 4 quarters · filed 2013-01-14
2011-08-31$891.24K
10-Q · filed 2012-10-12
$1.77M
derived: sum of 2 quarters · filed 2012-10-12
$2.62M
derived: sum of 3 quarters · filed 2012-10-12
$3.48M
derived: sum of 4 quarters · filed 2012-10-12
2011-05-31$878.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29
$1.72M
derived: sum of 2 quarters · filed 2012-08-29
$2.58M
derived: sum of 3 quarters · filed 2012-08-29
$3.37M
10-K · filed 2012-08-29
2011-02-28$846.42K
10-Q · filed 2012-04-16
$1.71M
derived: sum of 2 quarters · filed 2012-04-16
$2.50M
10-Q · filed 2012-04-16
2010-11-30$860.30K
10-Q · filed 2012-01-17
$1.65M
10-Q · filed 2012-01-17
2010-08-31$788.93K
10-Q/A · filed 2011-10-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92